Hepatitis B and liver cancerIn Africa, hepatitis B is the main cause of liver cancer, accounting for 80% of liver cancer cases. There is no specific treatment or cure for acute hepatitis B, and most ...
Poietis worked with pharmaceutical company Servier to develop a 4D bioprinted liver model that can better predict the liver toxicity of drugs. Hepatotoxicity testing is one of the key tests conducted...
British biotechnology company MiNA Therapeutics 'innovative RNA therapy may enhance liver cancer patients' response to standard treatment. The therapy uses a double-stranded RNA that can activate a t...
Hepatitis B is a virus that causes liver infection, and up to 80% of liver cancer patients are attributed to hepatitis B infection. Hepatitis B virus is highly contagious and has multiple modes of tr...
Effective drugs in liver cancerThe most effective drugs in liver cancer chemotherapy are doxorubicin (doxorubicin), 5-fluorouracil and cisplatin. But usually these drugs can only shrink the tumor, an...
When primary liver cancer is associated with ascites, jaundice, distant metastasis, etc., it is called advanced primary liver cancer. The treatment of advanced primary liver cancer is difficult, and ...
There are usually many problems that patients with liver cancer need to deal with, mainly including the following aspects:1) To deal with the side effects of the body, most treatments for liver cancer...
The end of active treatment does not mean the end of care for liver cancer patients. Follow-up care includes continuing to regularly check the physical condition of the liver cancer patient to ensure...
The traditional symptoms of liver cancer, such as a swollen abdomen or an enlarged liver, have many subtle signs that can easily be missed. Never ignore these signs, because early detection can get t...
August 19, 2018: Singapore biotechnology company Lion TCR Pte. Ltd. was approved by the Singapore Health Sciences Authority (HSA), and its candidate product (LioCyx ™) can be used for phase I / II c...